| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 10212* | 2020 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 6852 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 840 | 2021 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 701 | 2020 |
| Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 670 | 2020 |
| Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics M Ghoussaini, E Mountjoy, M Carmona, G Peat, EM Schmidt, A Hercules, ... Nucleic acids research 49 (D1), D1311-D1320, 2021 | 421 | 2021 |
| An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci E Mountjoy, EM Schmidt, M Carmona, J Schwartzentruber, G Peat, ... Nature genetics 53 (11), 1527-1533, 2021 | 363 | 2021 |
| Open Targets Platform: supporting systematic drug–target identification and prioritisation D Ochoa, A Hercules, M Carmona, D Suveges, A Gonzalez-Uriarte, ... Nucleic acids research 49 (D1), D1302-D1310, 2021 | 348 | 2021 |
| The next-generation Open Targets Platform: reimagined, redesigned, rebuilt D Ochoa, A Hercules, M Carmona, D Suveges, J Baker, C Malangone, ... Nucleic acids research 51 (D1), D1353-D1359, 2023 | 191 | 2023 |
| Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs D Ochoa, M Karim, M Ghoussaini, DG Hulcoop, EM McDonagh, I Dunham Nat Rev Drug Discov 21 (8), 551, 2022 | 134 | 2022 |
| Mapping local patterns of childhood overweight and wasting in low-and middle-income countries between 2000 and 2017 Nature medicine 26 (5), 750-759, 2020 | 113 | 2020 |
| Bangladesh: a success case in combating childhood diarrhoea SM Billah, S Raihana, NB Ali, A Iqbal, MM Rahman, ANS Khan, F Karim, ... Journal of global health 9 (2), 2019 | 58 | 2019 |
| Coding and regulatory variants are associated with serum protein levels and disease V Emilsson, V Gudmundsdottir, A Gudjonsson, T Jonmundsson, ... Nature Communications 13 (1), 481, 2022 | 46* | 2022 |
| Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity J Zheng, Y Zhang, H Zhao, Y Liu, D Baird, MA Karim, M Ghoussaini, ... EBioMedicine 81, 2022 | 31* | 2022 |
| Whole-exome sequencing identifies rare genetic variants associated with human plasma metabolites L Bomba, K Walter, Q Guo, P Surendran, K Kundu, S Nongmaithem, ... The American Journal of Human Genetics 109 (6), 1038-1054, 2022 | 28 | 2022 |
| A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance M Anisul, J Shilts, J Schwartzentruber, J Hayhurst, A Buniello, ... elife 10, e69719, 2021 | 28 | 2021 |
| Plasma triglycerides as a risk factor for chronic kidney disease in type 2 diabetes mellitus: evidence from northeastern Thailand SB Zaman, MA Karim, N Hossain, GM Al Kibria, SMS Islam diabetes research and clinical practice 138, 238-245, 2018 | 26 | 2018 |
| Systemic inflammation is associated with incident stroke and heart disease in East Asians MA Karim, C Kartsonaki, DA Bennett, IY Millwood, MR Hill, D Avery, ... Scientific reports 10 (1), 5605, 2020 | 25 | 2020 |
| Mining a GWAS of severe Covid-19 M Karim, I Dunham, M Ghoussaini N. Engl. J. Med 383 (26), 2588-2589, 2020 | 22 | 2020 |
| A community-based cluster randomised controlled trial to evaluate the effectiveness of different bundles of nutrition-specific interventions in improving mean length-for-age z … SM Billah, TE Ferdous, MA Karim, MJ Dibley, S Raihana, M Moinuddin, ... BMC Public Health 17, 1-12, 2017 | 20 | 2017 |
